WASHINGTON (Reuters) – Generic abortion pill maker GenBioPro Inc sued the U.S. Food and Drug Administration on Wednesday to keep mifepristone on the market amid ongoing legal challenges, according to documents filed in the U.S. District Court in Maryland.
(Reporting by Brendan Pierson and Susan Heavey; Editing by Doina Chiacu)
